Abstract

DAT-Cnr2 mice are conditional knockout (cKO) animals that do not express cannabinoid CB2 receptors (CB2R), in midbrain dopamine neurons. The hyperactivity phenotype of DAT-Cnr2 cKO mice were paradoxically reduced by low dose of amphetamine. Here, we report on the locomotor activity analysis in male and female adolescent (PND 30 ± 2) mice in basal conditions and in response to different doses of amphetamine, using the Open Field (OF), Elevated Plus-Maze (EPM) tests and the Novel Object Recognition (NOR) task as a putative model of attention deficit hyperactivity disorder (ADHD). Results showed that both male and female adolescent DAT-Cnr2 mice displayed significant increases in distance traveled in the OF test compared with WT mice. However, 2 mg/kg dose of amphetamine reduced the distance traveled by the DAT-Cnr2 but was increased in the WT mice. In the EPM test of anxiety-like behavioral responses, DAT-Cnr2 spent more time in the open arms of the maze than the WT mice, suggesting a reduction in anxiety-like response. DAT-Cnr2 mice showed significant increase in the number of unprotected head dips in the maze test and in the cliff avoidance reaction (CAR) test demonstrating impulsivity and risky behavior. DAT-Cnr2 mice also exhibited deficient response in the delay decision making (DDM), with impulsive choice. Both DAT-Cnr2 and WT were able to recognize the new object in the NOR task, but the exploration by the DAT-Cnr2 was less than that of the WT mice. Following the administration of 2 mg/kg of amphetamine, the similarities and differential performances of the DAT-Cnr2 and WT mice in the EPM test and NOR task was probably due to increase in attention. Microglia activation detected by Cd11b immunolabelling was enhanced in the hippocampus in DAT-Cnr2 cKO than in WT mice, implicating neuro-immune modulatory effects of CB2R. The results demonstrates that DAT-Cnr2 cKO mice with cell-type specific deletion of CB2R in midbrain dopaminergic neurons may represent a possible model for studying the neurobiological basis of ADHD.

Highlights

  • The study of cannabinoid compounds, such as 9-THC, the psychoactive molecule in Cannabis sativa, led to the discovery first of specific receptors and to a new system in the mammalian body: the endocannabinoid system (ECS) [1]

  • The time spent in the center for DA transporters (DAT)-Cnr2 was higher than the wild type (WT) female mice, but did not reach the time spent by the DAT-Cnr2 mice

  • The administration of a single low dose of amphetamine induced a paradoxical effect characterized by a significant reduction of the locomotor activity response in the DAT-Cnr2 mice, while producing a significant increase in the locomotor activity response of WT animals

Read more

Summary

Introduction

The study of cannabinoid compounds, such as 9-THC, the psychoactive molecule in Cannabis sativa, led to the discovery first of specific receptors and to a new system in the mammalian body: the endocannabinoid system (ECS) [1]. The eCBome is widely distributed throughout the body [3, 4]. The ECS is a lipid signaling system, which is functionally active at the early stages of brain development, and plays a neuromodulatory role in several behaviors [3, 5, 6]. A functional role of the ECS in neurological and psychiatric disorders has been implicated, for example: Parkinson’s disease, anxiety, depression, schizophrenia, attention deficit hyperactivity disorder (ADHD), among others [7, 8]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call